SCHEMBL6156845

SCHEMBL6156845

[CH2]C1CC(c2ccc(F)cc2)=NO1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.57
APAF1 O14727 1/20 0.57
GRK2 P25098 1/20 0.57
APOBEC3G Q9HC16 1/20 0.57
RAB9A P51151 6/20 0.48
NPC1 O15118 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CASP1 P29466 1/20 0.48
CYP2C19 P33261 3/20 0.47
CYP3A4 P08684 2/20 0.47
CYP1A2 P05177 2/20 0.47
ATM Q13315 1/20 0.47
MAPK10 P53779 4/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CYP2C9 P11712 2/20 0.45
MAPT P10636 2/20 0.43
ALDH1A1 P00352 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8578277 0.81 MAOB (0.50) POLBAPAF1GRK2APOBEC3GSMN1; SMN2
SCHEMBL10586602 0.81 CA1 (0.53) RAB9ANPC1CYP2C19CYP1A2MEN1
SCHEMBL6155050 0.81 CA1 (0.50) ATM
SCHEMBL6156849 0.78 POLB (0.57) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL6853296 0.74 POLB (0.53) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL5997363 0.74 APAF1 (0.53) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL5994929 0.74 POLB (0.56) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL6021765 0.74 POLB (0.56) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL21066152 0.74 POLB (0.53) POLBAPAF1GRK2APOBEC3GRAB9A
SCHEMBL5994924 0.74 POLB (0.56) POLBAPAF1GRK2APOBEC3GRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933283-B2 11-deoxy azalide antibacterials ABBOTT LABORATORIES (US) 2005-08-23 US claimed
EP-1501847-A2 11-DEOXY AZALIDE ANTIBACTERIALS Abbott Laboratories (US) 2005-02-02 EP claimed
US-20040014953-A1 11-Deoxy azalide antibacterials ABBVIE INC. 2004-01-22 US claimed
WO-2003090679-A2 11-DEOXY AZALIDE ANTIBACTERIALS ABBOTT LABORATORIES (US) 2003-11-06 WO claimed
US-6933283-B2 11-deoxy azalide antibacterials ABBOTT LABORATORIES (US) 2005-08-23 US disclosed
EP-1501847-A2 11-DEOXY AZALIDE ANTIBACTERIALS Abbott Laboratories (US) 2005-02-02 EP disclosed
US-20040014953-A1 11-Deoxy azalide antibacterials ABBVIE INC. 2004-01-22 US disclosed
WO-2003090679-A2 11-DEOXY AZALIDE ANTIBACTERIALS ABBOTT LABORATORIES (US) 2003-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014953-A1 11-Deoxy azalide antibacterials TOP1, TOP2B, TOP2A POLB 28/4885APAF1 2006/4885GRK2 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.